Xeris Biopharma Holdings (XERS) Accounts Payables (2020 - 2026)
Xeris Biopharma Holdings' (XERS) quarterly Accounts Payables came in at $11.5 million in Q1 2026, up 80.53% YoY from $6.4 million in Q1 2025, and up 272.79% on a QoQ basis from $3.1 million in Q4 2025.
Xeris Biopharma Holdings (XERS) Accounts Payables (2020 - 2026) Analysis & Trends
Xeris Biopharma Holdings (XERS) has 7 years of Accounts Payables data on file, last reported at $11.5 million in Q1 2026.
- Quarterly Accounts Payables rose 80.53% year-over-year to $11.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.5 million (up 80.53% YoY) and the FY2025 annual result came in at $3.1 million, up 34.32% from the prior year.
- Accounts Payables advanced to $11.5 million in Q1 2026, from $3.1 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $12.1 million in Q3 2023 to a low of $2.3 million in Q4 2024.
- A 5-year average of $7.8 million and a median of $7.1 million in 2024 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2023 — Accounts Payables soared 208.43% — and 2024, when it sank 80.2%.
- Tracing XERS's Accounts Payables over 5 years: stood at $4.6 million in 2022, then jumped by 151.09% to $11.6 million in 2023, then slumped by 80.2% to $2.3 million in 2024, then soared by 34.32% to $3.1 million in 2025, then jumped by 272.79% to $11.5 million in 2026.
- The last three Accounts Payables figures came in at $11.5 million (Q1 2026), $3.1 million (Q4 2025), and $6.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 356.00 Mn |
| 10 | Xeris Biopharma Holdings | 1.51 Bn | 1.39 Bn | 79.59 Mn | 9.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.34 Mn |
| Mar 31, 2026 | 11.47 Mn |
| Dec 31, 2025 | 3.08 Mn |
| Sep 30, 2025 | 6.53 Mn |
| Jun 30, 2025 | 9.46 Mn |
| Mar 31, 2025 | 6.35 Mn |
| Dec 31, 2024 | 2.29 Mn |
| Sep 30, 2024 | 7.45 Mn |
| Jun 30, 2024 | 5.80 Mn |
| Mar 31, 2024 | 7.09 Mn |
| Dec 31, 2023 | 11.57 Mn |
| Sep 30, 2023 | 12.08 Mn |
| Jun 30, 2023 | 11.62 Mn |
| Mar 31, 2023 | 11.98 Mn |
| Dec 31, 2022 | 4.61 Mn |
| Sep 30, 2022 | 3.92 Mn |
| Jun 30, 2022 | 6.63 Mn |
| Mar 31, 2022 | 11.09 Mn |
| Dec 31, 2021 | 8.92 Mn |
| Sep 30, 2021 | 4.29 Mn |